The Sun Pharmaceutical Industries Ltd announced approval from Indian drug authority known as the Drugs Controller General of India (DCGI) to launch a clinical trial with Nafamostat Mesylate in COVID-19 patients. A drug approved in Japan for improvement of acute...
TrialSite News reports that state attorneys general of more than 40 states filed a lawsuit accusing the nation’s largest generic drug makers of conspiring to inflate drug prices by over 1,000% in some cases. Filed in the United District Court for the District of...
The FDA reported that the U.S. Food and Drug Administration approved the first generic version of Sabril (vigabatrin) 500 mg tablets for treating complex partial seizures, also called focal seizures, as an adjunctive therapy (given with another primary treatment) in...
The Brainstorm study, supported by Saban Research Institute of Children’s Hospital Los Angeles. As reported in EurekaAlert! The study results are being published in the June 22, 2018 issue of the Journal of Science. The research points to the fact that a number of...
